Case Study: Science 37 advances remote clinical trials with ISBX's NORA platform

Science 37 powers remote clinical trials with ISBX for Genentech, Sanofi, and Novartis

Science 37, a startup aiming to make clinical trials more accessible, wanted to eliminate the barriers of traditional sites, such as geographical inaccessibility and inconvenient site visits. They partnered with the vendor ISBX to develop a solution for this challenge.

ISBX developed the NORA platform, which included a mobile app for patients to monitor their progress and video conference with medical staff, and a web dashboard for researchers to analyze data. This solution allowed Science 37 to successfully conduct remote clinical trials for major biotech companies. The vendor ISBX helped the startup achieve significant success, culminating in a planned IPO at a valuation of $1.4 billion.

Science 37